Covered recipient · General Payments record
COREY E ENNIS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$1,666.94
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $644.89 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $196.36 | 15 |
| Novo Nordisk AS | $143.84 | 7 |
| Amgen Inc. | $79.08 | 4 |
| PFIZER INC. | $60.22 | 3 |
| Otsuka America Pharmaceutical, Inc. | $28.11 | 1 |
| Astellas Pharma US Inc | $27.52 | 1 |
| Exact Sciences Corporation | $26.39 | 1 |
| Alexion Pharmaceuticals, Inc. | $26.07 | 1 |
| SANOFI PASTEUR INC. | $21.49 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.04 | 1 |
| Lilly USA, LLC | $17.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.17 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074353 | CMS |
| ABBVIE INC. | $15.36 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074355 | CMS |
| ABBVIE INC. | $3.14 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074357 | CMS |
| ABBVIE INC. | $7.80 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074359 | CMS |
| ABBVIE INC. | $14.89 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074361 | CMS |
| ABBVIE INC. | $4.70 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074363 | CMS |
| ABBVIE INC. | $18.57 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074365 | CMS |
| ABBVIE INC. | $21.76 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074367 | CMS |
| ABBVIE INC. | $23.00 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074369 | CMS |
| ABBVIE INC. | $19.37 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074371 | CMS |
| ABBVIE INC. | $21.29 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074373 | CMS |
| ABBVIE INC. | $15.58 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074375 | CMS |
| ABBVIE INC. | $5.41 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074377 | CMS |
| ABBVIE INC. | $12.31 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074379 | CMS |
| ABBVIE INC. | $5.01 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107074381 | CMS |
| Alexion Pharmaceuticals, Inc. | $26.07 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094011075 | CMS |
| Amgen Inc. | $15.72 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117549121 | CMS |
| Amgen Inc. | $24.24 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117549123 | CMS |
| Amgen Inc. | $18.67 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117549125 | CMS |
| Amgen Inc. | $20.45 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117549127 | CMS |
| Astellas Pharma US Inc | $27.52 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139510041 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.04 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118232224 | CMS |
| Exact Sciences Corporation | $26.39 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114447645 | CMS |
| Lilly USA, LLC | $17.77 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135629325 | CMS |
| Novo Nordisk Inc | $18.76 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100384869 | CMS |
| Novo Nordisk Inc | $17.78 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100336058 | CMS |
| Novo Nordisk Inc | $17.08 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263200 | CMS |
| Novo Nordisk Inc | $22.58 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100479901 | CMS |
| Novo Nordisk Inc | $24.65 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100335712 | CMS |
| Novo Nordisk Inc | $16.43 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100539404 | CMS |
| Novo Nordisk Inc | $26.56 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100390516 | CMS |
| Otsuka America Pharmaceutical, Inc. | $28.11 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119066540 | CMS |
| PFIZER INC. | $24.46 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131534728 | CMS |
| PFIZER INC. | $16.51 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132008170 | CMS |
| PFIZER INC. | $19.25 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131755214 | CMS |
| SANOFI PASTEUR INC. | $21.49 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128751983 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.